跳至主導覽 跳至搜尋 跳過主要內容

Late outcomes of endovascular aortic stent graft therapy in patients with chronic kidney disease

  • Chung Cheng Wu
  • , An Hsun Chou
  • , Yu Sheng Lin
  • , Victor Chien Chia Wu
  • , Shang Hung Chang
  • , Pao Hsien Chu
  • , Yu Ting Cheng
  • , Po Jen Ko
  • , Kuo Sheng Liu
  • , Shao Wei Chen*
  • , Robert Chen
  • *此作品的通信作者
  • Division of Thoracic and Cardiovascular Surgery
  • Chang Gung Memorial Hospital
  • Chang Gung University
  • Department of Cardiology

研究成果: 期刊稿件 › 文章 › 同儕審查

11 引文 斯高帕斯(Scopus)

摘要

AbstractEndovascular aneurysm repair (EVAR) and thoracic endovascular aortic repair (TEVAR) are effective and minimally invasive treatment options for high-risk surgical candidates. Nevertheless, knowledge about the management of aortic stent graft therapy in chronic kidney disease (CKD) is scarce. This study aimed to examine outcomes after EVAR and TEVAR in patients with CKD.Utilizing data from the Taiwan National Health Insurance Research Database, we retrospectively assessed patients who underwent EVAR and TEVAR therapy between January 1, 2006, and December 31, 2013. Patients were divided into CKD and non-CKD groups. Outcomes were in-hospital mortality, all-cause mortality, readmission, heart failure, and major adverse cardiac and cerebrovascular events.There were 1019 patients in either group after matching. The CKD group had a higher in-hospital mortality rate than the non-CKD group (15.2% vs 8.3%, respectively; odds ratio, 1.92; 95% confidence interval [CI], 1.46-2.54). Patients with CKD had higher risks of all-cause mortality including in-hospital death (46.1% vs 33.1%; hazard ratio [HR], 1.61; 95% CI, 1.35-1.92), readmission rate (62.6% vs 55.0%; subdistribution HR [SHR], 1.61; 95% CI, 1.32-1.69), redo stent (7.8% vs 6.2%; SHR, 1.50; 95% CI, 1.09-2.07), and major adverse cardiac and cerebrovascular events (13.3% vs 8.8%; SHR, 1.50; 95% CI, 1.15-1.95). The subgroup analysis did not demonstrate a variation in mortality between the TEVAR and EVAR cohorts (P for interaction = .725). The dialysis group had higher risks of all-cause mortality and readmission than the CKD without dialysis and non-CKD groups.Among EVAR/TEVAR recipients, CKD was independently associated with higher in-hospital mortality, postoperative complication, and all-cause mortality rates. Patients with end-stage renal disease on dialysis had worse outcomes than those in the CKD non-dialysis and non-CKD groups.

原文英語
頁(從 - 到)E22157
期刊Medicine (United States)
卷99
發行號37
DOIs
出版品狀態已出版 - 11 09 2020
對外發佈是

文獻附註

Publisher Copyright:
© 2020 Lippincott Williams and Wilkins. All rights reserved.

UN SDG

此研究成果有助於以下永續發展目標

  1. SDG3 健康與福祉
    SDG3 健康與福祉

指紋

深入研究「Late outcomes of endovascular aortic stent graft therapy in patients with chronic kidney disease」主題。共同形成了獨特的指紋。

引用此